There was an about 30% higher risk of developing type 2 diabetes among men with benign prostatic hyplasia who took the 5-alpha-reductase inhibitors dutasteride or finasteride, compared to tamsulosin users, according to a study in The BMJ. Researchers recruited men in Taiwan and the UK and advised reviewing "the way we monitor our patients to make sure we are extra vigilant for early signs of diabetes," said study author Laurence Stewart.
Men who take prostate cancer drugs at increased risk of diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.